Pharmacological rescue of mutant CFTR protein improves the viscoelastic properties of CF mucus

Riordan, 2008, CFTR function and prospects for therapy, Annu Rev Biochem, 77, 701, 10.1146/annurev.biochem.75.103004.142532 Gianotti, 2013, Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis, Am J Respir Cell Mol Biol, 49, 445, 10.1165/rcmb.2012-0408OC Pezzulo, 2012, Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung, Nature, 487, 109, 10.1038/nature11130 Quinton, 2008, Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis, Lancet, 372, 415, 10.1016/S0140-6736(08)61162-9 Voynow, 2009, Mucins, mucus, and sputum, Chest, 135, 505, 10.1378/chest.08-0412 King, 2005, Mucus and its role in airway clearance and cytoprotection, 409 Verdugo, 2012, Supramolecular dynamics of mucus, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a009597 Yang, 2013, Normal mucus formation requires cAMP-dependent HCO3- secretion and Ca2+-mediated mucin exocytosis, J Physiol, 591, 4581, 10.1113/jphysiol.2013.257436 Gustafsson, 2012, Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype, J Exp Med, 209, 1263, 10.1084/jem.20120562 Pedemonte, 2005, Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening, J Clin Invest, 115, 2564, 10.1172/JCI24898 Van Goor, 2011, Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809, Proc Natl Acad Sci U S A, 108, 18843, 10.1073/pnas.1105787108 Ramsey, 2011, A CFTR potentiator in patients with cystic fibrosis and the G551D mutation, N Engl J Med, 365, 1663, 10.1056/NEJMoa1105185 Okiyoneda, 2013, Mechanism-based corrector combination restores ΔF508-CFTR folding and function, Nat Chem Biol, 9, 444, 10.1038/nchembio.1253 Clancy, 2012, Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation, Thorax, 67, 12, 10.1136/thoraxjnl-2011-200393 Lai, 2007, Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus, Proc Natl Acad Sci U S A, 104, 1482, 10.1073/pnas.0608611104 Schuster, 2013, Nanoparticle diffusion in respiratory mucus from humans without lung disease, Biomaterials, 34, 3439, 10.1016/j.biomaterials.2013.01.064 Suk, 2009, The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles, Biomaterials, 30, 2591, 10.1016/j.biomaterials.2008.12.076 Qian, 1991, Single particle tracking. Analysis of diffusion and flow in two-dimensional systems, Biophys J, 60, 910, 10.1016/S0006-3495(91)82125-7 Wirtz, 2009, Particle-tracking microrheology of living cells: principles and applications, Annu Rev Biophys, 38, 301, 10.1146/annurev.biophys.050708.133724 Galietta, 1998, An improved method to obtain highly differentiated monolayers of human bronchial epithelial cells, In Vitro Cell Dev Biol Anim, 34, 478, 10.1007/s11626-998-0081-2 Kreindler, 2009, Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells, Am J Physiol Lung Cell Mol Physiol, 296, L257, 10.1152/ajplung.00344.2007 Scudieri, 2012, Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia, J Physiol, 590, 6141, 10.1113/jphysiol.2012.240838 Itani, 2011, Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance, Proc Natl Acad Sci U S A, 108, 10260, 10.1073/pnas.1106695108 Puchelle, 1985, Rheological and transport properties of airway secretions in cystic fibrosis—relationships with the degree of infection and severity of the disease, Eur J Clin Invest, 15, 389, 10.1111/j.1365-2362.1985.tb00290.x Henke, 2004, MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions, Am J Respir Cell Mol Biol, 31, 86, 10.1165/rcmb.2003-0345OC Rubin, 2007, Mucus structure and properties in cystic fibrosis, Paediatr Respir Rev, 8, 4, 10.1016/j.prrv.2007.02.004 Suh, 2005, Real-time multiple-particle tracking: applications to drug and gene delivery, Adv Drug Deliv Rev, 57, 63, 10.1016/j.addr.2004.06.001 Cholon, 2014, Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis, Sci Transl Med, 6, 10.1126/scitranslmed.3008680 Veit, 2014, Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression, Sci Transl Med, 6, 10.1126/scitranslmed.3008889 Flume, 2012, Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation, Chest, 142, 718, 10.1378/chest.11-2672